title: Newer Intravenous Antibiotics in the Intensive Care Unit: Ceftaroline, Ceftolozane-Tazobactam, and Ceftazidime-Avibactam.
authors.affiliation: Kathryn A. Connor is Associate Professor and Clinical Specialist, Critical Care, St John Fisher College of Pharmacy, 3690 East Ave, Rochester, NY 14618 (kaconnor@sjfc.edu).
authors.forename: Kathryn A
authors.initials: KA
authors.lastname: Connor
mesh_terms: D061605:Administration, Intravenous; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D053961:Azabicyclo Compounds / Q000008:administration & dosage*; D001424:Bacterial Infections / Q000188:drug therapy*; D002442:Ceftazidime / Q000008:administration & dosage*; D002511:Cephalosporins / Q000008:administration & dosage*; D004338:Drug Combinations; D004502:Education, Medical, Continuing; D006801:Humans; D007362:Intensive Care Units; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000078142:Tazobactam; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents; D053961:Azabicyclo Compounds; D002511:Cephalosporins; D004338:Drug Combinations; C000595613:avibactam, ceftazidime drug combination; D010397:Penicillanic Acid; D002442:Ceftazidime; D000078142:Tazobactam